India Approves Its First Dengue Vaccine: What It Means for Public Health
India Approves Its First Dengue Vaccine: What It Means for Public Health
India has made a big milestone in their dengue fight by getting their first dengue vaccine approved. This happened after the Drug Controller General of India (DCGI) permitted them to market QDENGA, their dengue vaccine. This vaccine, brought to market by Takeda Biopharmaceuticals India, is a significant achievement for the prevention of dengue in people against one major mosquito-borne illness that the country deals with regularly.
Towards a future free of dengue, the introduction of a dengue vaccine will definitely provide much-needed support in controlling this deadly disease at the same time. We at Biophar Lifesciences are convinced that vaccination, disease prevention, and timely treatment of these factors together have a major impact on creating a healthy society. One of these is, for example, awareness about vaccination.
A Historic Milestone for India
For a long time, the prevention of dengue has centered around mosquito control, creating public awareness about dengue and timely medical interventions.
Besides these measures that helped reduce the spread of dengue infections, this new preventive vaccine, QDENGA, will also provide an additional option, helping in controlling disease spread. The vaccine was cleared for sale after a regulatory review carried out by the DCGI. It is now officially the first approved dengue vaccine in India. This landmark development is symbolic of India continuing to invest in public health and increasing people’s access to quality health services.
Understanding Dengue
Dengue is a virus transmitted by the bite of Aedes mosquitoes that are carrying the virus. It is a rapidly spreading mosquito-borne illness in the tropical and subtropical regions, such as India.
Common symptoms include:
High fever
Severe headache
Pain behind the eyes
Muscle and joint pain
Skin rash
Nausea and vomiting
Fatigue
At times, dengue may progress to a critical stage characterized by bleeding, shock (low blood pressure), or organ failure. Because of this, prompt diagnostic tests and timely medical treatment of the highest standard are a must.
Why the Dengue Vaccine Is Important?
The dengue disease puts millions of people at risk every year. Unfortunately, mosquito-borne illness outbreaks still continue to reach various parts of India after mosquito breeding has been checked.
Having a dengue vaccine will offer many advantages, like:
– more effective protection from the dengue virus
– decreased danger of developing serious disease
– smaller number of patients requiring hospitalization during the epidemic seasons.
– assisting national health policy
– increased trust in the healthcare system for preventive methods
The way to minimize the spread of dengue at the country level effectively is to employ dengue vaccination combined with mosquito control and public enlightenment.
Dengue Prevention Still Matters
A vaccine is a great invention, but it’s not the only protection we have against a disease.
In fact, it’s best if we combine vaccines with other regular prevention methods.
Do not let stagnant water form in any container.
Apply mosquito repellents regularly.
Dress in long clothes if mosquito bites are a bigger concern.
Protect your house from insects by getting a window screen and hanging a net in your bedroom.
Maintain a tidy home and its surroundings. If you do get bitten, the next best thing is to see a doctor straight away if you start having signs of dengue.
A broad-spectrum solution is the best way to prevent and control dengue transmission.
Biophar Pharma’s Commitment to Better Healthcare
Biophar Lifesciences is a big supporter of innovations that could make our diseases easier to treat and our environment better and safer for all people. One such example is the recent granting of a license for a dengue vaccine, India’s first one of its kind. This is an illustration of the impact that joint effort between the fields of research, science, and healthcare can have to protect people from many infectious diseases.
Biophar Lifesciences is continuing its role by spreading information that can be helpful to the public on what measures can be taken for preventing diseases and, at the same time, also providing quality pharmaceutical products. Alongside this, it is acting as a catalyst to promote responsible healthcare systems that ultimately benefit patient outcomes for the better.
Conclusion
After years of delay and multiple trials, the government of India has finally approved the introduction of a dengue vaccine. This will be a great relief to the people suffering from dengue, as it would mean one less vector to fight with, namely a vaccine. This would go hand-in-hand with the already existing disease control measures such as mosquito abatement, early detection and treatment, and raising public awareness so that the number of dengue cases can be drastically reduced and, as a result, many more people can be protected.
From a company’s point of view, Biophar Life Sciences supports the idea that better medications, prevention of diseases, and health education should be the main tools and weapons in the battle for a healthier and safer world for all the inhabitants of this earth. So, they support and advocate these three aspects.